Patients with MDS or AML diagnosed before 1 January 2000 or on and after 1 January 2000
| . | Before 01/01/2000 . | After 01/01/2000 . | Total . |
|---|---|---|---|
| Patients with MDS/AML | 29 | 48 | 77 |
| Patients with chemotherapy only, n (%) | 10 (34) | 8 (20) | 18 (23) |
| Living | 0 | 0 | 0 |
| Deceased | 9 (90) | 8 (100) | 17 (90) |
| Lost to follow-up | 1 (10) | 0 | 1 |
| Patients with chemotherapy and HSCT, n (%) | 19 (66) | 40 (83) | 59 (77) |
| Living | 5 (26) | 18 (45) | 23 (39) |
| Deceased | 14 (74) | 22 (55) | 36 (61) |
| Lost to follow-up | 0 | 0 | 0 |
| . | Before 01/01/2000 . | After 01/01/2000 . | Total . |
|---|---|---|---|
| Patients with MDS/AML | 29 | 48 | 77 |
| Patients with chemotherapy only, n (%) | 10 (34) | 8 (20) | 18 (23) |
| Living | 0 | 0 | 0 |
| Deceased | 9 (90) | 8 (100) | 17 (90) |
| Lost to follow-up | 1 (10) | 0 | 1 |
| Patients with chemotherapy and HSCT, n (%) | 19 (66) | 40 (83) | 59 (77) |
| Living | 5 (26) | 18 (45) | 23 (39) |
| Deceased | 14 (74) | 22 (55) | 36 (61) |
| Lost to follow-up | 0 | 0 | 0 |